Trials / Completed
CompletedNCT01850706
UNGF Assessment in Patients With Detrusor Overactivity Undergoing Sacral Neuromodulation
Evaluation of Urinary Nerve Growth Factor as an Objective Tool to Assess Therapeutic Outcome in Patients With Detrusor Overactivity Undergoing Treatment With Sacral Neuromodulation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Northwell Health · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to find a noninvasive test to help physicians diagnose detrusor overactivity (DO), to use this urine test to help diagnose bladder problems, determine if treatments are working, and determine if patients are good candidates for interventions like sacral neuromodulation/Interstim Therapy.
Conditions
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2013-05-09
- Last updated
- 2016-10-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01850706. Inclusion in this directory is not an endorsement.